The Latest Breaking News from XLV

Powell’s dovish Jackson Hole remarks signal that the Fed could cut rates as early as September, with markets now pricing an 80% chance of a 25 bps cut.

Incyte has outperformed the health care sector over the past year, and analysts are moderately optimistic about the stock’s prospects.

Agilent Technologies has underperformed the healthcare sector lately, and analysts are moderately optimistic about the stock’s potential.

Cencora has outperformed other healthcare stocks over the past year and analysts remain bullish about the stock’s prospects.

Despite Stryker’s outperformance relative to the healthcare sector over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.

The healthcare sector is poised for strong growth, driven by ongoing advancements in medical technology, demographic trends, and increased healthcare spending. Thus, to gain exposure to the healthcare sector, one could consider investing in quality ETFs: iShares Global Healthcare (IXJ), Vanguard Health Care (VHT), and Health Care Select Sector SPDR…

Healthcare ETFs offer diversified exposure across resilient subsectors and combine defensive qualities with long-term growth potential. Therefore, investors could consider buying strong healthcare ETFs, such as iShares U.S. Healthcare (IYH), Vanguard Health Care Index Fund (VHT), and The Health Care Select Sector (XLV). Read more….

IDXX Laboratories has recently underperformed the Healthcare sector, but Wall Street analysts are moderately optimistic about the stock’s prospects.

Futures: Meta Platforms boomed on earnings, but megacap techs can't hide broad market rally weakness. First Republic dived again.